Theodore B Schwartz

Summary

Country: USA

Publications

  1. ncbi The UGDP controversy: thirty-four years of contentious ambiguity laid to rest
    Theodore B Schwartz
    Department of Medicine, Rush University Medical Center, USA
    Perspect Biol Med 47:564-74. 2004

Detail Information

Publications1

  1. ncbi The UGDP controversy: thirty-four years of contentious ambiguity laid to rest
    Theodore B Schwartz
    Department of Medicine, Rush University Medical Center, USA
    Perspect Biol Med 47:564-74. 2004
    ..The development of newer sulfonylurea drugs that do not block ischemic preconditioning has rendered the UGDP controversy moot and has preserved a place for sulfonylureas in the treatment of type 2 diabetes...